Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001410578-25-000808
Filing Date
2025-04-21
Accepted
2025-04-21 06:05:17
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A enfn-20241231x10ka.htm   iXBRL 10-K/A 736329
2 EX-31.1 enfn-20241231xex31d1.htm EX-31.1 4636
3 EX-31.2 enfn-20241231xex31d2.htm EX-31.2 4645
  Complete submission text file 0001410578-25-000808.txt   1205477

Data Files

Seq Description Document Type Size
4 EX-101.SCH enfn-20241231.xsd EX-101.SCH 4964
5 EX-101.DEF enfn-20241231_def.xml EX-101.DEF 53879
6 EX-101.LAB enfn-20241231_lab.xml EX-101.LAB 32827
7 EX-101.PRE enfn-20241231_pre.xml EX-101.PRE 25675
20 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20241231x10ka_htm.xml XML 14222
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40949 | Film No.: 25851242
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)